We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Novartis now faces competition to its top-seller Gleevec, a treatment for chronic myeloid leukemia, as Sun Pharma launched its copycat version in the U.S. Monday. Read More
Eli Lilly has teamed up with health insurer Anthem to draft a pair of position papers asking federal regulators and legislators to fundamentally rethink the way manufacturers and payers interact. Read More
The war on high pharmaceutical prices continues, with PBM Express Scripts taking aim at what it calls an excessive price jump for Valeant Pharmaceuticals’ diabetes drug Glumetza. Read More
Two Alabama compounders face federal charges for selling tainted drugs that contributed to the deaths of nine people, according to federal prosecutors. Read More
Sharp price spikes for some orphan generics may be getting all of the attention today, but they have little real impact on overall prescription drug prices. Read More
After serving as Gilead Sciences’ CEO for 20 years, John C. Martin announced Friday that he is stepping down and will assume the role of executive chairman of the company. Read More